Facebook
X
LinkedIn
Forward
University of Chicago Pancreas Symposium: Pancreatic Cysts and Cancer
Chicago, IL US
January 31, 2026
Join Us for a Cutting-Edge Exploration in Pancreatic Care
Discover the latest breakthroughs in the diagnosis and management of pancreatic cysts and cancer through a dynamic, interdisciplinary program designed for today’s healthcare professionals. This activity goes beyond the basics, delivering expert insights on evolving medical, oncologic, interventional, and surgical approaches that are transforming patient outcomes. Gain essential updates on advanced diagnostic tools, surgical innovations, novel chemotherapeutic strategies, and the growing role of molecular profiling in guiding personalized care. Don’t miss this opportunity to sharpen your skills and stay ahead in a rapidly changing field. Sign up today!
Target Audience
This activity is designed for gastroenterologists, surgeons, oncologists, interventional endoscopists, anesthesiologists, psychologists, hospitalists, internists, advanced practice nurses, physician assistants, trainees, registered dietitians, and nurses dedicated to caring for patients with pancreatic cysts and pancreatic cancer.
Learning Objectives
After this activity, participants will be able to:
- Interpret molecular diagnostics and surveillance strategies to enhance early detection of pancreatic cancer in high-risk individuals;
- Apply current evidence-based guidelines to the surveillance and management of pancreatic cystic neoplasms;
- Manage complications of pancreatic cancer treatment using surgical, endoscopic, and supportive care approaches;
- Incorporate patient and caregiver perspectives to improve communication, empathy, and culturally competent care in pancreatic disease management;
- Evaluate advances in endoscopic ultrasound, surgical, and systemic therapies for the diagnosis and management of pancreatic ductal adenocarcinoma.
You may also be interested in
| Time | Session | Faculty |
|---|---|---|
| 7:30 AM | REGISTRATION & BREAKFAST | |
| 8:00 AM | Welcome Remarks and Program Overview | Bradford Chong, MD, Mitchell Posner, MD, Uzma Siddiqui, MD |
| Diagnosis and Treatment of Pancreatic Ductal Adenocarcinoma | Moderator: Bradford Chong, MD | |
| 8:20 AM | Diagnosis, Staging, and Surveillance for Pancreatic Ductal Adenocarcinoma with Endoscopic Ultrasound | Vanessa Shami, MD |
| 8:40 AM | Surgery First vs. Upfront Chemotherapy for Resectable & Borderline Pancreatic Cancer | Mitchell Posner, MD |
| 9:00 AM | Updates on Systemic Therapies, the Role of Molecular Markers, and Personalized Therapy for Metastatic Pancreatic Cancer | Ardaman Shergill, MD |
| 9:20 AM | Panel Discussion | Session 1 Faculty |
| 9:40 AM | BREAK | |
| Cystic and Other Solid Lesions of the Pancreas | Moderator: Dennis Chen, MD | |
| 9:50 AM | Making Sense of Guidelines in Pancreatic Cystic Neoplasms | Vanessa Shami, MD |
| 10:10 AM | Surgical Management of IPMNs: When to Cut? | Jeffrey Matthews, MD |
| 10:30 AM | Approach to Pancreatic Neuroendocrine Tumors: Observe, Resect, or Enucleate? | Xavier Keutgen, MD |
| 10:50 AM | EUS-Guided Ablation of Pancreatic Cysts | Tamas Gonda, MD |
| 11:10 AM | Panel Discussion | Session 2 Faculty |
| 11:30 AM | LUNCH | |
| Complications of Pancreatic Cancer Treatment: Minimizing and Managing | Moderators: Eric Montminy, MD, Grace Kim, MD | |
| 12:10 PM | Minimally Invasive and Robotic Pancreatic Surgery: Ready for Prime Time? | Cecilia Ong, MD |
| 12:30 PM | Endoscopic Palliation of Malignant Biliary and Gastric Outlet Obstruction | Uzma Siddiqui, MD |
| 12:50 PM | Pancreatic Cancer Pain and Therapies | Magdalena Anitescu, MD, PhD |
| 1:10 PM | Pancreatic Insufficiency After Resection | Bradford Chong, MD |
| 1:30 PM | Panel Discussion | Session 3 Faculty |
| 1:50 PM | BREAK | |
| Early Detection and Prevention in Pancreatic Cancer | Moderator: Sonia Kupfer, MD | |
| 2:00 PM | Molecular Analysis in Pancreatic Cysts | Tamas Gonda, MD |
| 2:20 PM | High-Risk Individuals and Surveillance for Pancreatic Ductal Adenocarcinoma | Christine Drogan, MS |
| 2:40 PM | Patient Panel: Navigating The Experience of Pancreatic Cancer Screening and Early Detection | Patient Advocate, Caregiver, Session 4 Faculty |
| 3:00 PM | ADJOURN |
The agenda is subject to change.
University of Chicago Gleacher Center
450 Cityfront Plaza Dr
Chicago, IL
60611
United States
GLEACHER CENTER
Built to meet the demanding requirements of the top-ranked University of Chicago Booth School of Business, the Gleacher Center offers an outstanding educational environment. Steps from North Michigan Avenue, the six-story, 50,000-square-foot venue was meant to foster the interaction of people and ideas.
You will find all that Chicago has to offer right outside the doors of the Gleacher Center. This includes boat tours on the river, world-class shopping on Chicago's famed Michigan Avenue, museums, dining options that range from a casual drink at a nearby tavern to a four-course meal at one of many fine dining establishments, and much more!
TRAVEL AND PARKING
Click here for directions to the Gleacher Center. Click here for parking information.
VISITING CHICAGO
Discover why Condé Nast Traveler readers voted Chicago the Best Big City in the U.S. for a historic eighth year in a row. To help plan your stay in Chicago, visit Choose Chicago.
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office at 773-702-8597 or via email.
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, the University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
UNIVERSITY OF CHICAGO PLANNING COMMITTEE
Mitchell C. Posner, MD -- Course DirectorThomas D. Jones Distinguished Service Professor of Surgery
Professor of Radiation and Cellular Oncology
Chief Clinical Officer & Physician-in-Chief, UCM Comprehensive Cancer Center
Chief, Section of General Surgery
Uzma D. Siddiqui, MD -- Course DirectorProfessor of Medicine
Director, Center for Endoscopic Research & Therapeutics
Alaine Kamm, DNP, ACNP-BCNurse Practitioner
Disclosure Declarations
As a provider accredited by the ACCME, the University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an educational activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships before the start of the activity.
Additionally, the University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration at first mention and where appropriate in the content.
As a provider accredited by the ACCME, the University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an educational activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships before the start of the activity.
Additionally, the University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration at first mention and where appropriate in the content.
Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credit
University of Chicago Medicine is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Participants who successfully complete the entire activity and complete an evaluation form will earn 5.75 contact hours.
Nursing Credit
University of Chicago Medicine is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Participants who successfully complete the entire activity and complete an evaluation form will earn 5.75 contact hours.
American Board of Internal Medicine MOC II Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Other Participant Credit
Other participants will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Please note: The credit claiming process will close three months after the conference end date. Requests to claim credit after three months may incur additional fees.
EXHIBIT OPPORTUNITIES AVAILABLE!
Showcase your company’s innovations in pancreatic diagnostics, surgery, and oncology to a high-impact audience of gastroenterologists, surgeons, oncologists, and other specialists. This cutting-edge symposium brings together leaders in pancreatic cyst and cancer management for a day of dynamic, interdisciplinary learning.
Exhibiting offers a prime opportunity to connect directly with decision-makers, demonstrate your products and services, and strengthen your presence in this rapidly evolving field. Don’t miss your chance to engage with clinicians advancing the future of pancreatic care!
Download the 
prospectus or contact Amy Majkowski via email or at 773-702-8598. We hope to see you there!
prospectus or contact Amy Majkowski via email or at 773-702-8598. We hope to see you there!REGISTRATION
Space is limited, so register today! Click the button below to get started!
| Profession Type | Fee |
|---|---|
| Physicians | $75 |
| Other Healthcare Professionals | $50 |
| Trainees | $0 |
| A credit card processing fee will apply. | |
CLAIMING CREDIT
Enter the access code below to unlock the credit-claiming process.
Please note: Requests to claim MOC Part II credit must be made within one month to report to ABIM. Requests to claim AMA PRA Category 1 Credit™ after three months may incur additional fees.
Please login or create an account to proceed.